LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

Search

Quanterix Corp

Fechado

SetorSaúde

6.43 -2.58

Visão Geral

Variação de preço das ações

24h

Atual

Mín

6.42

Máximo

6.48

Indicadores-chave

By Trading Economics

Rendimento

-3.5M

-34M

Vendas

16M

40M

Margem de lucro

-83.479

Funcionários

471

EBITDA

5.7M

-31M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+16.1% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

80M

318M

Abertura anterior

9.01

Fecho anterior

6.43

Sentimento de Notícias

By Acuity

80%

20%

346 / 374 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Neutral Evidence

Quanterix Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

24 de dez. de 2025, 21:41 UTC

Aquisições, Fusões, Aquisições de Empresas

Nvidia to Buy Chip-Designer Groq for $20 Billion, CNBC Reports

28 de dez. de 2025, 23:57 UTC

Ganhos

'Avatar: Fire and Ash' Tops Domestic Box Office Again -- Barrons.com

28 de dez. de 2025, 23:48 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

28 de dez. de 2025, 23:48 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

28 de dez. de 2025, 23:48 UTC

Conversa de Mercado

Nikkei May Rise on Weaker Yen -- Market Talk

28 de dez. de 2025, 10:30 UTC

Aquisições, Fusões, Aquisições de Empresas

There's No Happy Ending for Movie Theaters, No Matter Who Wins Warner -- Heard on the Street -- WSJ

26 de dez. de 2025, 20:22 UTC

Conversa de Mercado

Oil Loses Ground On Russia-Ukraine Peace Efforts -- Market Talk

26 de dez. de 2025, 20:13 UTC

Conversa de Mercado

U.S. Natural Gas Gains on Colder Weather Outlook -- Market Talk

26 de dez. de 2025, 19:24 UTC

Aquisições, Fusões, Aquisições de Empresas

Nvidia's Groq Deal Is an Instagram Moment -- With 1 Big Risk -- Barrons.com

26 de dez. de 2025, 17:45 UTC

Conversa de Mercado

U.S. Diesel Down on Lower Crude Prices, Freight-Sector Lull -- Market Talk

26 de dez. de 2025, 15:52 UTC

Conversa de Mercado

Oil Futures Turn Lower After Steady Start -- Market Talk

26 de dez. de 2025, 14:58 UTC

Conversa de Mercado

Silver, Gold Reach New Highs Amid Geopolitical Tension -- Market Talk

26 de dez. de 2025, 14:41 UTC

Conversa de Mercado

U.S. Natural Gas Futures Look to End Week Higher -- Market Talk

26 de dez. de 2025, 14:28 UTC

Conversa de Mercado

Dollar Indexes Flat as Yen Rally Wanes -- Market Talk

26 de dez. de 2025, 13:47 UTC

Conversa de Mercado

Oil Futures Steady in Thin Holiday Trade -- Market Talk

26 de dez. de 2025, 07:22 UTC

Conversa de Mercado

Comex Gold Futures' Strong Bullish Momentum in Play, Chart Shows -- Market Talk

26 de dez. de 2025, 05:03 UTC

Conversa de Mercado

Malaysian Ringgit Likely to Face Pressure From Dollar Strength in 1Q -- Market Talk

26 de dez. de 2025, 03:38 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

26 de dez. de 2025, 03:38 UTC

Conversa de Mercado

Korean Won Strengthens, Supported by Verbal Interventions -- Market Talk

26 de dez. de 2025, 02:44 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

26 de dez. de 2025, 02:44 UTC

Conversa de Mercado

Singapore Dollar Weakens Slightly on Likely Position Adjustments -- Market Talk

26 de dez. de 2025, 01:39 UTC

Conversa de Mercado

China's Central Bank Signals Possibility of Easing Policy in Coming Months -- Market Talk

26 de dez. de 2025, 01:14 UTC

Conversa de Mercado

Oil Edges Higher Amid Geopolitical Tensions -- Market Talk

26 de dez. de 2025, 00:34 UTC

Conversa de Mercado

Yen Mostly Weakens Amid Risk-on Sentiment -- Market Talk

26 de dez. de 2025, 00:15 UTC

Conversa de Mercado

Nikkei Gains 0.6%, Led by Tech, Videogame Stocks -- Market Talk

25 de dez. de 2025, 23:42 UTC

Conversa de Mercado

Nikkei May Trade in Range; Yen in Focus -- Market Talk

25 de dez. de 2025, 23:40 UTC

Conversa de Mercado

Gold Edges Higher Amid Geopolitical Risks -- Market Talk

25 de dez. de 2025, 00:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Nike Climb Boosts Dow, S&P 500 -- 2nd Update

24 de dez. de 2025, 22:22 UTC

Aquisições, Fusões, Aquisições de Empresas

Nvidia, Groq Strike AI Tech Licensing Deal -- Barrons.com

24 de dez. de 2025, 21:26 UTC

Aquisições, Fusões, Aquisições de Empresas

Nvidia to Buy Chip-Designer Groq for $20B, CNBC Reports

Comparação entre Pares

Variação de preço

Quanterix Corp Previsão

Preço-alvo

By TipRanks

16.1% parte superior

Previsão para 12 meses

Média 7.5 USD  16.1%

Máximo 8 USD

Mínimo 7 USD

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Quanterix Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

2 ratings

0

Comprar

2

Manter

0

Vender

Pontuação Técnica

By Trading Central

5.34 / 6.015Suporte e Resistência

Curto Prazo

Neutral Evidence

Médio Prazo

Bullish Evidence

Longo Prazo

No Evidence

Sentimento

By Acuity

346 / 374 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat